Recent Updates
Recently added Catalysts

Physician Introduction of research personnel

Phase 2

Critical Care Trial Participation Consent by SDM | Unknown | Other |Unity Biotechnology, Inc.|Last Updated: Jan 7, 2013

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedACTIVE_CONTROLLEDBiomarker
Total Trials1
Total Enrollment138
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01232621The Approach StudyPHASE2 COMPLETED 138Jul 1, 2011Nov 1, 2012Jan 7, 20131 Canada
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Feasibility Outcome
7 days

Feasibility of the pilot study will be assessed by the following: 1. We expect that (i) ≤ 15% of physician introductions will be missed due to lack of physician availability (physician introduction arm) and (ii) cross-overs (from either arm to the other) will occur in ≤ 15% on introductions. 2. Following randomization, we expect that ≤ 20% of introductions will be missed due to inability of the RC to contact existing SDMs once identified (either intervention or control arm). 3. We will obtain at least 70% of initial SDM questionnaires Part A and at least 50% of questionnaires Part B.

Secondary Endpoints
Consent Obtained Vs Consent Declined
7 days
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeHEALTH_SERVICES_RESEARCH
Treatment Arms
ArmTypeDescription
Physician introductionEXPERIMENTALPhysicians will introduce Research Coordinators (RCs) by name to SDMs and acknowledge patient eligibility to participate in a study using a standardized script.
Non-physician introduction (usual approach)ACTIVE_COMPARATORRCs will either introduce themselves or be introduced by a non-physician member of the health care team.
Interventions
NameTypeDescription
Physician Introduction of research personnelOTHERPhysicians will introduce Research Coordinators (RCs) by name and acknowledge patient eligibility to participate in a research study using a standardized script.
Unlock Study Design Details
Eligibility Criteria
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * SDMs of critically ill adults who are eligible (meet all inclusion criteria and have no exclusion criteria) to participate in a critical care research study in progress in the ICU Exclusion Criteria: * Eligible critically ill adults who die or are transferred out of a partic...

Countries:Canada
Unlock Eligibility Criteria